Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic Escherichia coli intestinal colonization in a rabbit model
Authors:
- 16 November 2023
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 91 (11) , e0027223
Abstract
There are no vaccines licensed against enterotoxigenic Escherichia coli (ETEC), a leading cause of children’s diarrhea and the most common cause of travelers’ diarrhea. Multivalent vaccine candidate MecVax unprecedentedly targets two ETEC enterotoxins (heat-stable toxin, STa; heat-labile toxin, LT) and the seven most prevalent ETEC adhesins (colonization factor antigen, CFA/I, coli surface antigens, CS1–CS6) and has been demonstrated preclinically to protect against STa- and LT-mediated ETEC clinical diarrhea and prevent intestinal colonization from ETEC strain H10407 (CFA/I, STa, LT). However, it is unattested whether MecVax broadly protects against intestinal colonization from ETEC strains producing the other six adhesins (CS1–CS6) also targeted by this product. In this study, we immunized rabbits with MecVax and challenged them with heterogeneous ETEC strains that express CS1–CS6 adhesins to evaluate MecVax’s efficacy against bacterial intestinal colonization, thus providing broad vaccine protection against ETEC infection. Data revealed that rabbits intramuscularly immunized with MecVax developed robust responses to both ETEC enterotoxins (STa, LT) and seven adhesins (CFA/I, CS1–CS6), and when challenged with ETEC isolates expressing CS1/CS3, CS2/CS3, CS4/CS6, CS5/CS6, or CS6 adhesin, the immunized rabbits prevented over two logs (>99%) of bacteria from colonization in small intestines. Additionally, compared to a CFA-toxoid fusion protein, which is another potential ETEC vaccine antigen to target two ETEC enterotoxins and the seven adhesins, MecVax exhibited better protection against ETEC intestinal colonization. These results, in conjunction with the protection data from early studies, evidenced that MecVax is broadly protective, validating MecVax’s candidacy as an effective vaccine against ETEC-associated diarrhea and accelerating ETEC vaccine development.Keywords
Funding Information
- HHS | National Institutes of Health (R01AI121067-O1A1)
- HHS | National Institutes of Health (R01AI175214-01)
- HHS | National Institutes of Health (R01AI177144-01)
This publication has 36 references indexed in Scilit:
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)The Lancet Global Health, 2015
- An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and childrenVaccine, 2015
- Characterization of Heat-Stable (STa) Toxoids of Enterotoxigenic Escherichia coli Fused to Double Mutant Heat-Labile Toxin Peptide in Inducing Neutralizing Anti-STa AntibodiesInfection and Immunity, 2014
- Multiepitope Fusion Antigen Induces Broadly Protective Antibodies That Prevent Adherence of Escherichia coli Strains Expressing Colonization Factor Antigen I (CFA/I), CFA/II, and CFA/IVClinical and Vaccine Immunology, 2013
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control studyThe Lancet, 2013
- Progress and hurdles in the development of vaccines against enterotoxigenicEscherichia coliin humansExpert Review of Vaccines, 2012
- Modified Heat-Stable Toxins (hSTa) of Enterotoxigenic Escherichia coli Lose Toxicity but Display Antigenicity after Being Genetically Fused to Heat-Labile Toxoid LT(R192G)Toxins, 2011
- A systematic review of ETEC epidemiology focusing on colonization factor and toxin expressionVaccine, 2011
- Genetic Fusions of Heat-Labile (LT) and Heat-Stable (ST) Toxoids of Porcine EnterotoxigenicEscherichia coliElicit Neutralizing Anti-LT and Anti-STa antibodiesInfection and Immunity, 2010
- Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in BangladeshInfection and Immunity, 2007